顶流基金经理最新持仓曝光，年回报率最高近65%

Market Overview - In Q4 2025, market volatility increased, with A-shares and Hong Kong stocks ending the year amidst fluctuations. The Shanghai Composite Index rose by 2.22%, while the CSI 300 Index fell by 0.23%, and the ChiNext Index decreased by 1.08%. The Hang Seng Index dropped by 4.56%, and the Hang Seng China Enterprises Index fell by 6.72% [1][18]. Sector Performance - Despite the overall market performance being lackluster, there was a stark contrast within sectors. The technology growth sectors, represented by AI computing power and semiconductors, performed exceptionally well, while industries such as real estate, pharmaceuticals, and computers faced pressure [1][19]. Fund Manager Strategies - Star fund managers like Fu Pengbo and Li Xiaoxing achieved significant excess returns in Q4 2025, with Fu's Ruiyuan Growth Value Fund and Li's Yinhua Small Cap Select both rising over 60% for the year, driven by heavy investments in AI computing power and semiconductors [2][19]. - Balanced allocation funds, such as Zhu Shaoxing's Fuguo Tianhui Select Growth A, showed stable performance with over 20% annual growth, benefiting from diversified holdings across finance, consumption, and manufacturing sectors [2][19]. Technology Sector Focus - Fu Pengbo's Ruiyuan Growth Value Fund increased its allocation to data center liquid cooling and related companies, with the top ten holdings now concentrated at 70.38%. The fund's top three holdings include Xinyi Solar, Shenghong Technology, and CATL [4][22]. - Li Xiaoxing's Yinhua Small Cap Select emphasized AI hardware innovation and application investment opportunities, with seven of its top ten holdings in the semiconductor industry, reflecting a shift towards advanced process breakthroughs and domestic chip investments [23][24]. Traditional Value Sector - Fund managers like Zhang Kun, Liu Yanhun, and Ge Lan continued to focus on traditional assets such as consumption and pharmaceuticals. Zhang's E-Fund Blue Chip Select maintained a stable stock position, emphasizing confidence in the long-term prospects of the Chinese consumer market [24][25]. - Ge Lan's China Europe Medical Health A faced net value pressure in Q4 2025, with all top ten holdings experiencing negative returns, despite previous positive performance [26][27]. Policy and Market Sentiment - Fund managers noted that "anti-involution" policies are becoming key variables affecting corporate fundamentals, with expectations for improved business environments and competition dynamics [31]. - Despite market rebounds and rising valuations, many managers believe that equity assets still hold significant allocation value, particularly in light of changes in traditional high-yield channels [32]. Importance of Stock Selection - The emphasis on stock selection has intensified, with fund managers highlighting the need for deep research and careful selection of companies with core advantages, especially in a concentrated market environment [33].